Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2002 Oct;43(10):464-467.
doi: 10.1111/j.1748-5827.2002.tb00015.x.

Immunosuppressive cytokines in the regional lymph node of a dog suffering from oral malignant melanoma

B Catchpole  1 , S M Gould  2 , L M Kellett-Gregory  1 , J M Dobson  2
Affiliations
Case Reports

Immunosuppressive cytokines in the regional lymph node of a dog suffering from oral malignant melanoma

B Catchpole et al. J Small Anim Pract. 2002 Oct.

Abstract

A 10-year-old male cross-breed dog was referred for investigation of oral malignant melanoma. Fine-needle aspirates were taken from the draining submandibular lymph node. The presence of metastatic melanoma cells was confirmed by cytological examination and reverse transcription polymerase chain reaction (RT-PCR) using primers for the melanoma-associated antigens: tyrosinase and mart-1/melan A. Cytokine expression in the lymph node was evaluated by multiplex RT-PCR, which demonstrated the presence of mRNA for IL-10 and TGF-beta1. However, IL-2, IL-4 and IFNgamma mRNA could not be detected, suggesting a lack of immune activation. Thoracic radiographs showed a lesion within the caudal lung fields suggestive of pulmonary metastasis. The dog developed signs of dyspnoea and collapse and was euthanased four days later. This case illustrates that molecular techniques can be used to aid clinical staging of canine oral malignant melanoma, and suggests that immunosuppressive cytokines could be involved in the pathogenesis of disease.

PubMed Disclaimer

References

    1. Blackwood, L. & Dobson, J. M. (1996) Radiotherapy of oral malignant melanoma in dogs. Journal of the American Veterinary Medical Association 209, 98-102.
    1. Brunner, C., Seiderer, J., Schlamp, A., Bidlingmaier, M., Eigler, A., Haimerl, W., Lehr, H. A., Kreig, A. M., Hartmann, G. & Endres, S. (2000) Enhanced dendritic cell maturation by TNF-alpha or CpG DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. Journal of Immunology 165, 6278-6286.
    1. Cangul, I. T., Van Garderen, E., Van Der Poel, H. J. A., Weijer, K. & Misdorp, W. (1999) Tyrosinase gene expression in clear cell sarcoma indicates a melanocytic origin: insight from the first reported canine case. Acta Pathologica Microbiologica Immunologica Scandinavica 107, 982-988.
    1. Catchpole, B., Kellett-Gregory, L. M. & Dobson, J. M. (2001) Immunosuppression in canine oral malignant melanoma: a role for IL-10? Immunology 104, 78.
    1. Chen, Q., Daniel, V., Maher, D. W. & Hersey, P. (1994) Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. International Journal of Cancer 56, 755-760.

Publication types

MeSH terms

LinkOut - more resources